Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 29, 2004

View Archived Issues

Organic nitrate prodrug RS-7897 shows improved pharmacological properties in dogs

ARC-111, a novel topoisomerase I antitumor candidate

Use of beta-blockers reduces fracture risk

Vanilloid agonists effective in detrusor hyperreflexia

Snail venom peptide CGX-1051 reduces infarction in rabbit models

Ro-1151240 in stress urinary incontinence

Novel glucocorticoid receptor modulators designed at Boehringer Ingelheim

GSK scientists develop novel dual ACE/NEP inhibitors

Phase III data for a fixed travoprost/timolol combination in glaucoma

New alpha7 nAchR agonists with utility in cognitive disorders claimed by Bayer

New IKK inhibitors and their use described by Boehringer Ingelheim scientists

Lipid profile changes found with pioglitazone and metformin in obese patients with type 2 diabetes

Wyeth team presents new guanidine-based 5-HT6 ligands

Selective or dual GSK-3/PKC inhibitors prepared and tested at Janssen

Different phototoxicity profiles found with fluoroquinolone antibiotics in healthy subjects

New antidiabetic glycogen phosphorylase inhibitors under study at Aventis

International health teams gear up for potential flu pandemic

Improved pregnancy rates found with Menopur in women undergoing IVF

Approval for Provigil expanded label

Niaspan completes European mutual recognition procedure

First European named patient sales of Voraxaze

SuperGen completes rolling NDA for Orathecin

AZD-3582 recommended for further development based on phase II results

Aventis rejects Sanofi-Synthelabo's offer

Immtech receives initial payment from MMV for DB-289 development

GenoMed launches common cold trial using ACE approach

Genta clarifies Genasense agreement terms

Esperion updates 2003 progress of four products in clinical development

Amgen reports Q4 and year-end 2003 highlights

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...